Tumor Viruses in CD30-Positive Anaplastic Large Cell Lymphomas

References

• Stein H., Mason D. Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H., Schwarting R., Lennert K. The expression of Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue. Evidence that Reed -Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–849
   PubMed Web of Science ®Google Scholar
• Stein H., Herbst H., Anagnostopoulos I., Niedobitek G., Dallenbach F., Kratzsch H. C. The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Ann. Oncol. 1991; 2(Suppl 2)33–38
   PubMedGoogle Scholar
• Agnarsson B. A., Kadin M. E. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am. J. Surg. Pathol. 1989; 12: 264–274
   Web of Science ®Google Scholar
• Stansfeld A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelenyi G., Sundstrom C., Lennert K., van Unnik J. A. M., Mioduszewska O., Wright D. H. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292–293
   PubMed Web of Science ®Google Scholar
• Schwarting R., Gerdes J., Dürkop H., Falini B., Pileri S., Stein H. BER-H 2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol resistant epitope. Blood 1989; 74: 1678–1689
   PubMed Web of Science ®Google Scholar
• Dürkop H., Latza U., Hummel M., Eitelbach F., Seed B., Stein H. Molecular cloning and expression of a new member of the nev growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992; 68: 421–427
   PubMed Web of Science ®Google Scholar
• Stein H., Dienemann D., Dallenbach F., Kruschwitz M. Peripheral T-cell lymphomas. Ann. Oncol. 1991; 2(Suppl. 2)163–169
   PubMedGoogle Scholar
• Kaudewitz P., Herbst H., Anagnostopoulos I., Eckert F., Braun-Falco O., Stein H. Lymphomatoid papulosis followed by anaplastic large cell lymphoma: immunophenoty-pical and genotypical analysis. Br. J. Dermatol. 1991; 124: 465–469
   PubMed Web of Science ®Google Scholar
• Kaudewitz P., Stein H., Dallenbach F., Eckert F., Bieber K., Burg G., Braun-Falco O. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical characteristics. Am. J. Pathol. 1989; 135: 359–367
   PubMed Web of Science ®Google Scholar
• Engelhard M., Stein H., von Schilling C., Dallenbach F., Zwingers T., Feller A. C., Stein H., Lennert K. 1992, Immunomorphological and clinical characterization of CD30 (Ki-1) positive large cell lymphomas: Identification of three subgroups and their clinical behaviour. Blood, in press
   Google Scholar
• Falini B., Pileri S., Stein H., Dienamann D., Dallenbach F., Delsol G., Minelli O., Poggi F., Martelli M. F., Pallesen G., Palestro G. Variable expression of leukocyte common (CD45) antigen in CD30 (Ki-l)-positive anaplastic large-cell lymphoma. Implication for the differential diagnosis between lymphoid and non-lymphoid malignancies. Hum. Pathol. 1990; 21: 624–629
   PubMed Web of Science ®Google Scholar
• Delsol G., Al Saati T., Gatter K. C., Gerdes J., Schwarting R., Caveriviere P., Rigal-Huguet F., Robert A., Stein H., Mason D. Y. Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am. J. Pathol. 1988; 130: 59–70
   PubMed Web of Science ®Google Scholar
• Herbst H., Tippelmann G., Anagnostopoulos I., Gerdes J., Schwarting R., Boehm T., Pileri S., Jones D. B., Stein H. Immunoglobulin and T cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: Dissociation between genotype and phenotype. Leuk. Res. 1989; 13: 103–116
   PubMed Web of Science ®Google Scholar
• Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Muller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Stern berg cells. Proc. Natl. Acad. Sci. USA 1991; 88: 4766–4770
   PubMed Web of Science ®Google Scholar
• Peuchmaur M., Emilie D., Crevon M. C., Solal-Celigny P., Maillot M. C., Lemaigre G., Galanaud P. IL-2 mRNA expression in Tac-positive malignant lymphomas. Am. J. Pathoi. 1990; 136: 383–390
   PubMed Web of Science ®Google Scholar
• Merz H., Fliedner A., Orscheschek K., Binder T., Sebald W., Miiller-Hermelink H. K., Feller A. C. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am. J. Pathol. 1991; 139: 1173–1180
   PubMed Web of Science ®Google Scholar
• Merz H., Houssiau F. A., Orscheschek K., Renauld J. C., Fliedner A., Herin M., Noel H., Kadin M., Mueller-Hermelink H. K., van Snick J., Feller A. C. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 1991; 78: 1311–1317
   PubMed Web of Science ®Google Scholar
• O'Connor N. T. J., Gatter K. C., Crick J., Stein H., Wainscoat J. S., Delsol G., Al Saati T. Genotypic analysis of Ki-1 antigen positive lymphomas. Histopathology 1988; 11: 733–740
   Web of Science ®Google Scholar
• Rimokh R., Magaud J. P., Berger F., Samarut J., Comer B., Germain D., Mason D. Y. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (“Ki-1 lymphoma”). Br. J. Haematol. 1989; 71: 31–36
   PubMed Web of Science ®Google Scholar
• Le Beau M. M., Bitter M. A., Larson R. A., Doane L. A., Ellis E. D., Franklin W. A., Rubin C. M., Kadin M. E., Vardiman J. W. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 1989; 3: 866–870
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Frizzera G., Edamura S., Maseki N., Sakurai M., Komada Y., Sakurai M., Tanaka H., Sasaki M., Suchi T., Kikuta A., Wakasa H., Hojo H., Mizutani S. A novel translocation t(2;5)(p23;q35) in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 1989; 73: 806–813
   PubMed Web of Science ®Google Scholar
• Mason D. Y., Bastard C., Rimokh R., Dastague N., Huret J. L., Kristofferson U., Magaud J. P., Nezelof C., Tilly H., Vannier J. P., Hemet J., Warnke R. CD30-positive large cell lymphomas (“Ki-1 lymphoma”) are associated with a chromosomal translocation involving 5q35. Br. J. Haematol. 1990; 74: 161–168
   PubMed Web of Science ®Google Scholar
• Bitter M. A., Franklin W. A., Larson R. A., McKeithan T. W., Rubin C. M., Le Beau M. M., Stephens J. K., Vardiman J. W. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am. J. Surg. Pathol. 1990; 14: 305–316
   PubMed Web of Science ®Google Scholar
• Modi W. S., Pollock D. D., Mock B. A., Banner C., Renauld J. C., Van Snick J. Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization. Cytogenet. Cell Genet. 1991; 57: 114–116
   PubMedGoogle Scholar
• Kieff E., Liebowitz D. Epstein-Barr virus and its replication. In:. Virology, B. N. Fields, D. M. Knipe. Raven Press, New York 1990; 1889–-1920
   Google Scholar
• Miller G. Epstein-Barr virus. Biology, pathogenesis, and medical aspects. In:. Virology, D. M. Fields, D. M. Knipe. Raven Press, New York 1990; 1921–-1958
   Google Scholar
• Niedobitek G., Herbst H., Young L. S., Brooks L., Masucci M. G., Crocker J., Rickinson A. B., Stein H. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992; 79: 2520–2526
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Herbst H., Niedobitek G., Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern and in situ hybridization. Blood 1989; 74: 810–816
   PubMed Web of Science ®Google Scholar
• Borisch B., Gatter K. C., Tobler A., Theilkas L., Bunch C., Wainscoat J. S., Fey M. F. 1992, Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients. Histopathology98, in press
   Google Scholar
• Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883–889
   PubMed Web of Science ®Google Scholar
• Herbst H., Dallenbach F., Hummel M., Niedobitek G., Rowe M., Young L. S., Muller-Lantzsch N., Stein H. Epstein-Barr virus DNA and latent gene products in CD30-positive anaplastic large cell lymphomas. Blood 1991; 78: 2666–2673
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S. J., Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am. J. Pathol. 1992; 140: 1315–1326
   PubMed Web of Science ®Google Scholar
• Wang F., Gregory C., Sample C., Rowe M., Liebowitz D., Murray R., Rickinson A., Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 1990; 64: 2309–2318
   PubMed Web of Science ®Google Scholar
• Herbst H., Steinbrecher E., Niedobitek G., Finn T., Young L. S., Brooks L., Müller-Lantzsch N., Stein H. Distribution and phenotype of Epstein-Barr virus harboring cells in Hodgkin's disease. Blood 1992; 80: 484–491
   PubMed Web of Science ®Google Scholar
• Rowe M., Rowe D. T., Gregory C. D., Young L. S., Farrell P. J., Rupani H., Rickinson A. B. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EM BO J. 1987; 6: 2743–2747
   PubMed Web of Science ®Google Scholar
• Fahreaus R., Fu H. L., Ernberg I., Finke J., Rowe M., Klein G., Falk K., Nilsson E., Yadav M., Busson P., Tursz T., Kallin B. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer 1988; 42: 329–1000
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Croom-Carter D., Wang F., Longnecker L., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar
• Kneba M., Eick S., Herbst H., Willigeroth S., Pott C., Bolz I., Bergholz M., Neumann C., Stein H., Krieger G. Frequency and structure of t(14; 18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: Analysis by direct DNA sequencing. Cancer Res. 1991; 51: 3243–3250
   PubMed Web of Science ®Google Scholar
• Rowe M., Young L. S., Crocker J., Stokes H., Henderson S., Rickinson A. B. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J. Exp. Med. 1991; 173: 147–158
   PubMed Web of Science ®Google Scholar
• Moss D. J., Misko I. S., Burrows S. R., Burman K., McCarthy R., Sculley T. B. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 1988; 331: 719–721
   PubMed Web of Science ®Google Scholar
• Murray R. J., Wang D., Young L. S., Wang F., Rowe M., Kieff E., Rickinson A. B. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-encoded latent membrane protein LMP. J. Virol. 1988; 62: 3747–3755
   PubMed Web of Science ®Google Scholar
• Cann A. J., Chen I. S. Y. Human T-cell Leukemia virus types I and II. In:. Virology, D. M. Fields, D. M. Knipe. Raven Press, New York 1990; 1501–1527
   Google Scholar
• Wantzin G. L., Thomsen K., Nissen N. I., Saxinger C., Gallo R. C. Occurrence of human T cell lymphotropic virus (type I) antibodies in cutaneous T cell lymphoma. J. Am. Acad. Dermatol. 1986; 15: 598–602
   PubMed Web of Science ®Google Scholar
• Detmar M., Pauli G., Anagnostopoulos I., Wunderlich U., Herbst H., Garbe C., Stein H., Orfanos C. E. A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type I. Br. J. Dermatol. 1991; 124: 198–202
   PubMed Web of Science ®Google Scholar
• Hall W. W., Liu C. R., Schneewind O., Takahashi H., Kaplan M. H., Roupe G., Vahnle A. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 1991; 253: 317–320
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Hummel M., Kaudewitz P., Herbst H., Braun-Falco O., Stein H. Detection of HTLV-I proviral sequences in CD30-positive large cell cutaneous T-cell lymphomas. Am. J. Pathol. 1990; 137: 1317–1322
   PubMed Web of Science ®Google Scholar
• Lombardi L., Newcomb E. W., Della-Favera R. Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogenecauses the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 1987; 49: 161–170
   PubMed Web of Science ®Google Scholar
• Scala G., Quinto I., Rucco M. R., Arcucci A., Mallardo M., Caretto P., Forni G., Venuta S. Expression of an exogenous interleukin 6 gene in human Epstein-Barr virus B cells confers growth advantage and in vivo tumorigenicity. J. Exp. Med. 1990; 172: 61–68
   PubMed Web of Science ®Google Scholar
• Uyttenhove C., Druez C., Renauld J. C., Herin M., Noel H., Van Snick J. Antonomous growth and tumorigenicity induced by p40/IL-9 cDNA expression in a mouse p40-dependent T cell line. J. Exp. Med. 1991; 173: 519–522
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345–347
   PubMed Web of Science ®Google Scholar
• Gaidano G., Ballerini P., Gong J. Z., Inghirami G., Neri A., Newcomb E. W., Magrath I. T., Knowles D., Dalla-Favera R. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad Sci. USA. 1991; 88: 5413–5417
   PubMed Web of Science ®Google Scholar